Martin’S Sulfurane

AiCuris GmbH & Co. KG has been awarded a three-year research grant together with the Universities of Bochum, Düsseldorf and Bonn as well as the company Squarix (Marl). This grant is a part of the research promotion program “Bio.NRW” by the Ministry of Innovation, Science and Research of North Rhine- more

The global biotechnology industry has been more resistant to the economic crisis than expected. This has been one of the main conclusions of the international round table "Opportunities and Challenges of the Global Biomarkets", held as part of the 5th International Meeting on Biotechnology, BioSpain more

Affitech A/S announced that the Company's lead drug candidate r84, which may have therapeutic application against certain cancers, shows potent activity on tumours and does not induce significant side effects in mice. This is the conclusion of a study conducted by Rolf Brekken, University of Texas more

by Nathaniel C. Cady, Kurt A. McKean, Jason Behnke, Roman Kubec, Aaron P. Mosier, Stephen H. Kasper, David S. Burz, Rabi A. Musah Using a microplate-based screening assay, the effects on Pseudomonas aeruginosa PAO1 biofilm formation of several S-substituted cysteine sulfoxides and their c more

Production of 3,4-dihydroxy phenyl-l-alanine (l-DOPA) using an Egyptian isolate of halophilic black yeast was studied. Optimum aeration level and incubation period for high yield production of l-DOPA were 50 ml medium/250 ml flask with 200 rpm and 36 h, respectively. Two new techniques (addition of more